MedTrace Logo

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

NCT02415257 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2020-09-11

No results posted yet for this study

Summary

The purpose of the study is to determine whether vestibular and postural compensation following schwannoma surgery is improved by ablating vestibular function prior to surgery, even if vestibular function is absent according to modern assessment techniques

Conditions

  • Vestibular Schwannoma

Interventions

DRUG

Gentamicin

Intratympanic installation of gentamicin 2-4 times depending on the efficacy of vestibular deafferentation

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Fredrik Tjernström, MD, PhD · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02415257 on ClinicalTrials.gov